Cytek Biosciences Inc (CTKB) PT Lowered to $8.25 at Piper Sandler

November 25, 2024 8:19 AM EST Send to a Friend
Piper Sandler analyst Dave Westenberg lowered the price target on Cytek Biosciences Inc (NASDAQ: CTKB) to $8.25 (from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login